A new trading day began on Tuesday, with Perspective Therapeutics Inc (AMEX: CATX) stock price down -7.82% from the previous day of trading, before settling in for the closing price of $2.43. CATX’s price has ranged from $1.60 to $19.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.39%. Meanwhile, its annual earnings per share averaged -2.77%. With a float of $53.81 million, this company’s outstanding shares have now reached $70.67 million.
Let’s determine the extent of company efficiency that accounts for 140 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Perspective Therapeutics Inc (CATX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 27.34%, while institutional ownership is 67.92%. The most recent insider transaction that took place on Mar 28 ’25, was worth 49,384. In this transaction Chief Executive Officer of this company bought 22,026 shares at a rate of $2.24, taking the stock ownership to the 59,383 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 4,650 for $2.21, making the entire transaction worth $10,288. This insider now owns 4,650 shares in total.
Perspective Therapeutics Inc (CATX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.71% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Here are Perspective Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 114.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.21, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.44 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Looking closely at Perspective Therapeutics Inc (AMEX: CATX), its last 5-days average volume was 0.52 million, which is a drop from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 49.38%. Additionally, its Average True Range was 0.19.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 24.24%, which indicates a significant decrease from 54.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.62% in the past 14 days, which was higher than the 78.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.32, while its 200-day Moving Average is $7.28. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $2.37. Second resistance stands at $2.49. The third major resistance level sits at $2.59. If the price goes on to break the first support level at $2.15, it is likely to go to the next support level at $2.05. Should the price break the second support level, the third support level stands at $1.93.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
With a market capitalization of 165.87 million, the company has a total of 74,051K Shares Outstanding. Currently, annual sales are 1,450 K while annual income is -79,280 K. The company’s previous quarter sales were 230 K while its latest quarter income was -40,170 K.
